EA200601289A1 - Ненуклеозидные ингибиторы обратной транскриптазы - Google Patents

Ненуклеозидные ингибиторы обратной транскриптазы

Info

Publication number
EA200601289A1
EA200601289A1 EA200601289A EA200601289A EA200601289A1 EA 200601289 A1 EA200601289 A1 EA 200601289A1 EA 200601289 A EA200601289 A EA 200601289A EA 200601289 A EA200601289 A EA 200601289A EA 200601289 A1 EA200601289 A1 EA 200601289A1
Authority
EA
Eurasian Patent Office
Prior art keywords
alkyl
orx
nrxrx
reverse transcriptase
transcriptase inhibitors
Prior art date
Application number
EA200601289A
Other languages
English (en)
Other versions
EA009700B1 (ru
Inventor
Кристьян Сунд
Натали Роуэ
Стефан Линдстрем
Дмитрий Антонов
Кристер Сальберг
Катарина Янссон
Original Assignee
Медивир Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0400021A external-priority patent/SE0400021D0/xx
Priority claimed from SE0400585A external-priority patent/SE0400585D0/xx
Application filed by Медивир Аб filed Critical Медивир Аб
Publication of EA200601289A1 publication Critical patent/EA200601289A1/ru
Publication of EA009700B1 publication Critical patent/EA009700B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Предложены соединения формулы Z, где А представляет собой СН или N; Rпредставляет собой заместитель у атома углерода в кольце, содержащем А, который выбран из -S(=O)Ra, где Ra представляет собой -С-С-алкил, -ORx, -NRxRx, -NHNRxRx, -NHNHC(=O)ORx, -NRxOH; -C(=O)-Rb, где Rb представляет собой -С-С-алкил, ORx, -NRxRx, -NHNRxRx, -NHC-С-алкил-С(=O)ORx; -NRxRc, где Rc представляет собой Н, С-С-алкил, -NRxRx; -C(=O)Rd, -CN, S(=O)Rx, где Rd представляет собой С-С-алкил, -ORx, -NRxRx; -С-С-алкил-О-С-С-алкил-С(=O)ORx, -С-С-алкил-COORx; -C-С-алкил-ОН или его С-С-алкиловые простые или сложные эфиры; -(O-C-С-алкил)-O-Rx; или 5- или 6-членного атоматического кольца, содержащего 1-3 гетероатома; р принимает значения 1 или 2; Rx независимо выбран из Н, С-С-алкила или ацила; или пара Rx вместе с соседним атомом N может образовывать кольцо; L представляет собой -О-, -S(=O)- или -CH-, где r принимает значения 0, 1 или 2; R-Rпредставляют собой заместители, определенные в описании; Х представляет собой -(CRR')-D-(CRR')-; D представляет собой связь, -NR-, -О-, -S-, -S(=O)- или -S(=O)-; и их фармацевтически приемлемые соли и пролекарства, которые находят применение в качестве ВИЧ-противовирусных средств.
EA200601289A 2004-01-08 2004-12-30 Ненуклеозидные ингибиторы обратной транскриптазы EA009700B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0400021A SE0400021D0 (sv) 2004-01-08 2004-01-08 Non-nucleoside reverse transcriptase inhibitors
SE0400585A SE0400585D0 (sv) 2004-03-09 2004-03-09 NNRTI Antivirals
PCT/SE2004/002034 WO2005066131A1 (en) 2004-01-08 2004-12-30 Non-nucleotide reverse transcriptase inhibitors

Publications (2)

Publication Number Publication Date
EA200601289A1 true EA200601289A1 (ru) 2006-12-29
EA009700B1 EA009700B1 (ru) 2008-02-28

Family

ID=34752289

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200601289A EA009700B1 (ru) 2004-01-08 2004-12-30 Ненуклеозидные ингибиторы обратной транскриптазы

Country Status (16)

Country Link
US (1) US7915295B2 (ru)
EP (1) EP1701942B1 (ru)
JP (1) JP4762917B2 (ru)
AT (1) ATE451357T1 (ru)
AU (1) AU2004312284B2 (ru)
BR (1) BRPI0418306B8 (ru)
CA (1) CA2550187C (ru)
DE (1) DE602004024584D1 (ru)
DK (1) DK1701942T3 (ru)
EA (1) EA009700B1 (ru)
ES (1) ES2337794T3 (ru)
HK (1) HK1101400A1 (ru)
IL (1) IL176740A (ru)
NZ (1) NZ548367A (ru)
SG (1) SG149070A1 (ru)
WO (1) WO2005066131A1 (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1534276B1 (en) * 2002-09-05 2008-11-05 Medivir AB Non-nucleoside reverse transcriptase inhibitors
US7388008B2 (en) 2004-08-02 2008-06-17 Ambrilia Biopharma Inc. Lysine based compounds
CA2606025A1 (en) * 2005-04-27 2006-11-02 Ambrilia Biopharma Inc. Method for improving pharmacokinetics of protease inhibitors and protease inhibitor precursors
AU2006319716B2 (en) 2005-11-30 2012-02-02 Taimed Biologics, Inc. Lysine-based prodrugs of aspartyl protease inhibitors and processes for their preparation
GB0608876D0 (en) * 2006-05-05 2006-06-14 Medivir Ab Combination therapy
WO2007136573A2 (en) * 2006-05-15 2007-11-29 Merck & Co., Inc. Antidiabetic bicyclic compounds
JP5401652B2 (ja) 2006-09-21 2014-01-29 タイメッド バイオロジクス インコーポレイテッド プロテアーゼ阻害剤
EP3250552B1 (en) * 2015-01-30 2019-03-27 Genentech, Inc. Therapeutic compounds and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW470645B (en) 1998-01-16 2002-01-01 Medivir Ab Compound for inhibiting or preventing HIV infection, its preparation and pharmaceutical composition comprising same
WO1999051613A1 (en) * 1998-04-03 1999-10-14 Medivir Ab Prodrugs of phosphorous-containing pharmaceuticals
SE0100733D0 (sv) * 2001-03-05 2001-03-05 Medivir Ab Non-nucleoside reverse transcriptase inhibitors
SE0102867D0 (sv) 2001-08-28 2001-08-28 Medivir Ab Non-nucleoside reverse transcriptase inhibitors
EP1534276B1 (en) 2002-09-05 2008-11-05 Medivir AB Non-nucleoside reverse transcriptase inhibitors

Also Published As

Publication number Publication date
CA2550187C (en) 2012-08-07
JP2007519640A (ja) 2007-07-19
EP1701942B1 (en) 2009-12-09
BRPI0418306B8 (pt) 2021-05-25
NZ548367A (en) 2010-06-25
US20080070951A1 (en) 2008-03-20
JP4762917B2 (ja) 2011-08-31
DE602004024584D1 (de) 2010-01-21
AU2004312284A2 (en) 2005-07-21
WO2005066131A1 (en) 2005-07-21
AU2004312284B2 (en) 2010-08-05
DK1701942T3 (da) 2010-04-06
BRPI0418306B1 (pt) 2018-09-18
EA009700B1 (ru) 2008-02-28
ES2337794T3 (es) 2010-04-29
IL176740A (en) 2011-09-27
HK1101400A1 (en) 2007-10-18
IL176740A0 (en) 2006-10-31
SG149070A1 (en) 2009-01-29
US7915295B2 (en) 2011-03-29
CA2550187A1 (en) 2005-07-21
AU2004312284A1 (en) 2005-07-21
BRPI0418306A (pt) 2007-05-02
ATE451357T1 (de) 2009-12-15
EP1701942A1 (en) 2006-09-20

Similar Documents

Publication Publication Date Title
ES2525763T3 (es) Derivados del ácido fenilalcanoico sustituido y sus usos para el tratamiento de enfermedades respiratorias
AR038536A1 (es) N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
AR041009A1 (es) Compuestos heterociclicos nitrogenados que presentan actividad inhibitoria contra la integrasa del vih
CO5580777A2 (es) Inhibidores de hidroxipirimidinona carboxamida n-sustituidos de vih integrasa
EA200601289A1 (ru) Ненуклеозидные ингибиторы обратной транскриптазы
JP2005515210A5 (ru)
AR038888A1 (es) Amidas heterociclicas
WO2003106428A8 (fr) Derives d'arylsulfonamides et leur utilisation en tant que antagonistes au recepteur b1 de la bradykinine
CA2336807A1 (en) Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
AR050958A1 (es) Antibioticos biciclicos
RS52999B (en) BIS (AMIDIDA TIO-HYDRAZIDE) Salts for Cancer Treatment
BG108039A (en) Thiazolyl-, oxazolyl-, pyrrolyl- and amidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
RU2010103160A (ru) ПРОИЗВОДНЫЕ 2-[(2-{ФЕНИЛАМИНО}-1Н-ПИРРОЛО[2,3-d]ПИРИМИДИН-4-ИЛ)АМИНО]БЕНЗАМИДА В КАЧЕСТВЕ ИНГИБИТОРОВ IGF-1R ДЛЯ ЛЕЧЕНИЯ РАКА
HUP0300268A2 (hu) Herbicid hatású benzoilpirazolszármazékok, ilyeneket tartalmazó készítmények és alkalmazásuk
AR039112A1 (es) Inhibidores de quinasas
AR041271A1 (es) Quinazolinonas espirocondensadas y su uso como inhibidores de la fosfodiesterasa
RU2010115337A (ru) Трициклические гетероциклические производные
AR063636A1 (es) Derivados de indol y de benzofurano-2-carboxamida
AR038887A1 (es) Amidas heterociclicas
JP2006523698A5 (ru)
CO4950515A1 (es) Nuevos derivados de la quinolina para uso medicinal
AR036602A1 (es) Agonistas muscarinicos
RU2009102270A (ru) Производные тиазолилмочевины в качестве ингибиторов фосфатидилинозитол-3-киназы
TR200100603T2 (tr) Pirazin bileşikleri
RU2011119450A (ru) Содержащее конденсированную кольцевую структуру производное и его применение в медицине

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU